16

GASTROINTESTINAL DISORDERS

Gastricumeel as effective as PPIs in improving overall condition, and in overall assessment by the physician2

Clinical Effectiveness*

Change overall condition**

20

40

60

100

%

80

** P-value (between group differences) not significant

very much better much better slightly better worse not assessableunchanged

PPIs (n=193)

Gastricumeel (n=434)

Overall assessment of effectiveness of the therapy**

20

40

60

100

%

80

** P-value (between group differences) not significant

very good good satisfactory worsened not assessableno improvement

PPIs (n=183)

Gastricumeel (n=434)

Assessment of change in overall condition and overall therapy effectiveness were done at the end of the observation period

* Patients with dyspepsia (suspected new or recurring acute or chronic gastritis) or heartburn

References 2) Van Haselen, R., Cesnulevicius, K. Treatment of Dyspepsia, Heartburn, and Related Symptoms with Gastricumeel Compared to Proton Pump Inhibitors: A Prospective

Reference-Controlled Observational Study. Complement Med Res (2020): DOI: 10.1159/000511285. Online link: https://www.karger.com/Article/Fulltext/511285